PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $58,751 | -46.2% | 18,651 | -50.3% | 0.00% | -50.0% |
| Q2 2020 | $109,108 | +3.4% | 37,494 | +0.2% | 0.00% | 0.0% |
| Q1 2020 | $105,570 | -17.1% | 37,436 | -4.6% | 0.00% | 0.0% |
| Q4 2019 | $127,327 | +169.9% | 39,238 | +79.6% | 0.00% | +100.0% |
| Q3 2019 | $47,179 | -67.7% | 21,842 | -53.0% | 0.00% | -50.0% |
| Q2 2019 | $145,891 | -15.6% | 46,462 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $172,839 | +26.6% | 46,462 | -1.3% | 0.00% | 0.0% |
| Q4 2018 | $136,515 | +10.3% | 47,074 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $123,805 | -99.9% | 47,074 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $110,153,000 | -20.4% | 47,074 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $138,398,000 | +121301.8% | 47,074 | +12.9% | 0.00% | 0.0% |
| Q4 2017 | $114,000 | -70.7% | 41,688 | -63.7% | 0.00% | 0.0% |
| Q3 2017 | $389,000 | +35.5% | 114,844 | -1.3% | 0.00% | 0.0% |
| Q2 2017 | $287,000 | +14.8% | 116,377 | +5.7% | 0.00% | 0.0% |
| Q1 2017 | $250,000 | 0.0% | 110,091 | -6.8% | 0.00% | 0.0% |
| Q4 2016 | $250,000 | -36.1% | 118,076 | +1.1% | 0.00% | -33.3% |
| Q3 2016 | $391,000 | +7.7% | 116,837 | +1.2% | 0.00% | 0.0% |
| Q2 2016 | $363,000 | -5.5% | 115,462 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $384,000 | -6.1% | 115,462 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $409,000 | -29.6% | 115,462 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $581,000 | -9.2% | 115,462 | +16.1% | 0.00% | 0.0% |
| Q2 2015 | $640,000 | -28.4% | 99,457 | -21.7% | 0.00% | -42.9% |
| Q1 2015 | $894,000 | -9.1% | 127,017 | -0.4% | 0.01% | 0.0% |
| Q4 2014 | $983,000 | +3.3% | 127,469 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $952,000 | -25.5% | 127,469 | -3.4% | 0.01% | -22.2% |
| Q2 2014 | $1,277,000 | +21.0% | 131,917 | +3.9% | 0.01% | +28.6% |
| Q1 2014 | $1,055,000 | +4.9% | 126,998 | +6.6% | 0.01% | 0.0% |
| Q4 2013 | $1,006,000 | +5.9% | 119,167 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $950,000 | +3.3% | 119,167 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $920,000 | – | 119,167 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |